Recurrent Ischemic Stroke Lower With SGLT2i in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Stroke Read more about Recurrent Ischemic Stroke Lower With SGLT2i in T2DM
Tirzepatide Shows CV Event Reductions in T2DM Tags Coronary artery disease GLP-1 agonists Myocardial infarction Read more about Tirzepatide Shows CV Event Reductions in T2DM
OAC Risk Similar With SGLT2i and DPP4i in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about OAC Risk Similar With SGLT2i and DPP4i in T2DM
GLP-1 RAs Show Greater HbA1c Improvement vs DPP-4 Inhibitors Tags DPP-4 inhibitors GLP-1 agonists hBA1c Read more about GLP-1 RAs Show Greater HbA1c Improvement vs DPP-4 Inhibitors
MACE, Hypoglycemia Risks Differ Among Sulfonylureas Tags Coronary artery disease Hypoglycemia Sulphonylureas Read more about MACE, Hypoglycemia Risks Differ Among Sulfonylureas
Dose Escalation Linked to GI Tolerance With Incretins Tags GLP-1 agonists Read more about Dose Escalation Linked to GI Tolerance With Incretins
GLP-1RAs Rarely Used as Early Therapy in T2DM Tags GLP-1 agonists SGLT-2 Inhibitor Read more about GLP-1RAs Rarely Used as Early Therapy in T2DM
Can Fiber Improve Tolerance to GLP-1RA Therapy? Tags GLP-1 agonists Read more about Can Fiber Improve Tolerance to GLP-1RA Therapy?
GLP-1 Use Plus Healthy Habits Linked to Lower MACE in T2DM Tags Cardiomyopathy Coronary artery disease GLP-1 agonists Myocardial infarction Read more about GLP-1 Use Plus Healthy Habits Linked to Lower MACE in T2DM
Flash Monitoring Added to GLP-1RA Shows Greater HbA1c Reduction Tags GLP-1 agonists hBA1c Read more about Flash Monitoring Added to GLP-1RA Shows Greater HbA1c Reduction